Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism

被引:45
作者
Kato, K [1 ]
Sato, H [1 ]
Takebe, Y [1 ]
机构
[1] Natl Inst Infect Dis, Ctr AIDS Res, Lab Mol Virol & Epidemiol, Shinjuku Ku, Tokyo 1628640, Japan
关键词
D O I
10.1128/JVI.73.7.5520-5526.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To assess the role of naturally occurring basic amino acid substitutions in the V3 loop of human immunodeficiency virus type 1 (HN-I) subtype E on viral coreceptor usage and cell tropism, we have constructed a panel of chimeric viruses with mutant V3 loops of HIV-1 subtype E in the genetic background of HIV-1(LAI). The arginine substitutions naturally occurring at positions 8, 11, and 18 of the V3 loop in an HIV-1 subtype E X4 strain were systematically introduced into that of an R5 strain to generate a series of V3 loop mutant chimera. These chimeric viruses were employed in virus infectivity assays using HOS-CD4 cells expressing either CCR5 or CXCR4, peripheral blood mononuclear cells, T-cell lines, or macrophages. The arginine substitution at position 11 of the V3 loop uniformly caused the loss of infectivity in HOS-CD4-CCR5 cells, indicating that position 11 is critical for utilization of CCR5. CXCR4 usage was conferred by a minimum of two arginine substitutions, regardless of combination, whereas arginine substitutions at position 8 and 11 were required for T-cell line tropism. Nonetheless, macrophage tropism was not conferred by the V3 loop of subtype E R5 strain per se. We found that the specific combinations of amino acid changes in HIV-1 subtype E env V3 loop are critical for determining viral coreceptor usage and cell tropism, However, the ability to infect HOS-CD4 cells through either CXCR5 or CCR5 is not necessarily correlated with T-cell or macrophage tropism, suggesting that cellular tropism is not dictated solely by viral coreceptor utilization.
引用
收藏
页码:5520 / 5526
页数:7
相关论文
共 42 条
[1]   AN N-GLYCAN WITHIN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 V3 LOOP AFFECTS VIRUS NEUTRALIZATION [J].
BACK, NKT ;
SMIT, L ;
DEJONG, JJ ;
KEULEN, W ;
SCHUTTEN, M ;
GOUDSMIT, J ;
TERSMETTE, M .
VIROLOGY, 1994, 199 (02) :431-438
[2]   MACROPHAGE-TROPIC HUMAN-IMMUNODEFICIENCY-VIRUS ISOLATES FROM DIFFERENT PATIENTS EXHIBIT UNUSUAL V3 ENVELOPE SEQUENCE HOMOGENEITY IN COMPARISON WITH T-CELL-TROPIC ISOLATES - DEFINITION OF CRITICAL AMINO-ACIDS INVOLVED IN CELL TROPISM [J].
CHESEBRO, B ;
WEHRLY, K ;
NISHIO, J ;
PERRYMAN, S .
JOURNAL OF VIROLOGY, 1992, 66 (11) :6547-6554
[3]   Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4 [J].
Cho, MW ;
Lee, MK ;
Carney, MC ;
Berson, JF ;
Doms, RW ;
Martin, MA .
JOURNAL OF VIROLOGY, 1998, 72 (03) :2509-2515
[4]   The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates [J].
Choe, H ;
Farzan, M ;
Sun, Y ;
Sullivan, N ;
Rollins, B ;
Ponath, PD ;
Wu, LJ ;
Mackay, CR ;
LaRosa, G ;
Newman, W ;
Gerard, N ;
Gerard, C ;
Sodroski, J .
CELL, 1996, 85 (07) :1135-1148
[5]   The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection [J].
Cocchi, F ;
DeVico, AL ;
GarzinoDemo, A ;
Cara, A ;
Gallo, RC ;
Lusso, P .
NATURE MEDICINE, 1996, 2 (11) :1244-1247
[6]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS WITH INCREASED REPLICATIVE CAPACITY DEVELOP DURING THE ASYMPTOMATIC STAGE BEFORE DISEASE PROGRESSION [J].
CONNOR, RI ;
HO, DD .
JOURNAL OF VIROLOGY, 1994, 68 (07) :4400-4408
[7]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CLONES CHIMERIC FOR THE ENVELOPE V3 DOMAIN DIFFER IN SYNCYTIUM FORMATION AND REPLICATION CAPACITY [J].
DEJONG, JJ ;
GOUDSMIT, J ;
KEULEN, W ;
KLAVER, B ;
KRONE, W ;
TERSMETTE, M ;
DERONDE, A .
JOURNAL OF VIROLOGY, 1992, 66 (02) :757-765
[8]   MINIMAL REQUIREMENTS FOR THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 V3 DOMAIN TO SUPPORT THE SYNCYTIUM-INDUCING PHENOTYPE - ANALYSIS BY SINGLE AMINO-ACID SUBSTITUTION [J].
DEJONG, JJ ;
DERONDE, A ;
KEULEN, W ;
TERSMETTE, M ;
GOUDSMIT, J .
JOURNAL OF VIROLOGY, 1992, 66 (11) :6777-6780
[9]   Identification of a major co-receptor for primary isolates of HIV-1 [J].
Deng, HK ;
Liu, R ;
Ellmeier, W ;
Choe, S ;
Unutmaz, D ;
Burkhart, M ;
DiMarzio, P ;
Marmon, S ;
Sutton, RE ;
Hill, CM ;
Davis, CB ;
Peiper, SC ;
Schall, TJ ;
Littman, DR ;
Landau, NR .
NATURE, 1996, 381 (6584) :661-666
[10]   PHENOTYPE-ASSOCIATED SEQUENCE VARIATION IN THE 3RD VARIABLE DOMAIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 MOLECULE [J].
FOUCHIER, RAM ;
GROENINK, M ;
KOOTSTRA, NA ;
TERSMETTE, M ;
HUISMAN, HG ;
MIEDEMA, F ;
SCHUITEMAKER, H .
JOURNAL OF VIROLOGY, 1992, 66 (05) :3183-3187